Published in Cancer Weekly, February 8th, 2005
The trial results were published by researchers from the Indiana University School of Medicine, the University of Michigan, and Johns Hopkins University in the January 5, 2005, issue of the Journal of the National Cancer Institute.
The large clinical trial confirmed data from an earlier study showing that selective serotonin reuptake inhibitor (SSRI) antidepressants may hinder the effectiveness of tamoxifen, a drug commonly administered to breast cancer patients. The study also reported that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.